由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Military版 - 红脖过的惨和医生over pay很有关系
相关主题
花了全世界最多的钱在医疗上给你们讲两三个毛时代的实际例子,让那个euv见识见识什么叫平
药厂CEO这么惨?lenovo要火了,杨元庆把3个米的奖金发给员工赢得老美一片赞誉
Gilead 公司大会,问CEO有关武汉病毒所的专利申请 (ZT)美国的贫富差距已经要赶上1929年大萧条的时的峰值了
我帝跟我兔接轨了,加大对金融肃贪的力度为什么印度裔比华裔在美国更成功?
美国民航CEO们在DC作证以后再也不打乘客了,哈哈揭秘:为什么在美华人不如印度人成功? (转载)
高通准备放弃收购NXP理科生太谨慎,保守,稳重,所以当CEO的少
伟创力的CEO是个三妹Bannan:硅谷亚洲人是对公民社会的威胁
Science:2013年度生物技术与制药行业最佳雇主too many asian CEOs ,破床的主要军师说
相关话题的讨论汇总
话题: ceos话题: health话题: care话题: ceo话题: stock
进入Military版参与讨论
1 (共1页)
b****u
发帖数: 337
1
美国familiy中位数也就是5,6万。医生中位数要到20以上。5倍的差距。
提供发达国最差的服务。
美国医疗吸血能力仅次于墙街。
但是,墙街全世界吸血。 医疗可就只吸国内的血。
还有就是保险公司和医院医生狼狈为奸。
The richest year was 2015, when 70 health care CEOs collectively made $2
billion. That was an average of about $28.5 million per CEO and a median of
about $17.3 million per CEO. The median household income in 2015 was $56,515
, which the average health care CEO made in less than a day.2017年7月24日
he sky-high pay of health care CEOs
The CEOs of 70 of the largest U.S. health care companies cumulatively have
earned $9.8 billion in the seven years since the Affordable Care Act was
passed, and their earnings have grown faster than most Americans' during
that time, according to an Axios analysis of federal financial documents.
Why it matters: The ACA has not hurt the health care industry. Stock prices
have boomed, and CEOs took home nearly 11% more money on average every year
since 2010 — far outstripping the wage growth of nearly all Americans. But
the analysis also reveals that the pay packages for the country's
influential health care executives don't give them incentives to control
health care spending — something that economists, policymakers and even
Warren Buffett have said is the most pressing problem in health care.
Data: Analysis of company filings; Chart: Lazaro Gamio, Naema Ahmed / Axios
Show less
What we found: Total earnings amount to an average of $20 million (median of
$11 million) per CEO per year. A vast majority of pay came in the form of
vested stock.
The largest haul: John Martin, former CEO of the pharmaceutical company
Gilead Sciences, made $863 million in the ACA era — the most of any health
care CEO.
The big takeaway: Health care inflation continues to blow away general
economic inflation, and a big reason why is because health care executives
are not paid to slow spending.
What the analysis covers: The total CEO compensation (salary, bonuses, stock
, perks and retirement/severance when relevant) each year since 2010, when
the ACA went into effect, based on company filings with the Securities and
Exchange Commission.
These 70 corporations were chosen because they are based in the United
States and are among the largest publicly traded health care companies,
together encompassing more than $2 trillion of annual revenue. It did not
include the generous pay packages of not-for-profit hospital CEOs.
Our unique tabulation: We calculated the actual realized gains of CEOs'
stock options and awards (money that they had to pay taxes on), not the
estimated fair value of their stock shown in the federal filings' summary
compensation tables.
The estimated value of stock is misleading and does not accurately depict
how much a person made in a given year.
Actual realized gains show that CEOs are making a lot more than headlines
suggest.
William Lazonick, an economist at the University of Massachusetts Lowell,
and Matthew Hopkins, a senior researcher at the nonprofit Academic-Industry
Research Network, reviewed the analysis for accuracy. They have written
extensively about corporate executive compensation and why actual realized
stock gains matter.
"What is the relationship between their high pay and the role of stock
prices in their high pay and the problems of the health care system?"
Lazonick said. "There is a very close relationship, but it's not apparent to
most people."
The stock story: A gigantic portion of what CEOs make comes in the form of
vested stock, and those incentives drive their decision-making. The analysis
shows that since the ACA was passed, health care executives routinely took
measures to inflate stock prices — such as repurchasing shares or issuing
dividends to shareholders — that led to higher take-home pay.
Stock-heavy pay also drives CEOs to do the exact opposite of their buzzword-
laden goals of creating a "patient-centered" health system that focuses on "
value."
Actions that would benefit the broader health care system:
Lower prices
Eliminate unnecessary procedures, tests or devices
Coordinate care
Instead, CEOs often focus on what benefits the stock price:
Sell more prescription drugs
Perform more procedures and tests
Create new medical therapies that may not add value to someone's life
Raise prices above inflation
Do anything to create higher earnings per share
Here are the other main takeaways from the analysis:
Of the 113 health care CEOs in the analysis, only four were women. Two women
(Heather Bresch of Mylan and Debra Cafaro of Ventas) still lead their
companies.
Executives made slightly less as a group in 2016 than they did in 2015
because the presidential election dangled like an ax over the stock market.
The richest year was 2015, when 70 health care CEOs collectively made $2
billion. That was an average of about $28.5 million per CEO and a median of
about $17.3 million per CEO. The median household income in 2015 was $56,515
, which the average health care CEO made in less than a day.
Pharmaceutical and drug-related company CEOs made up 11 of the top 20
highest earners.
Gilead's Martin made the most since the ACA became law. Several other
executives — including John Hammergren of McKesson ($587 million), Leonard
Schleifer of Regeneron Pharmaceuticals ($338 million) and Stephen Hemsley of
UnitedHealth Group ($279 million) — each took home more than a quarter-
billion dollars on their own.
A handful of lesser-known health care CEOs were among the highest earners.
For example, Michael Mussallem of the medical device company Edwards
Lifesciences collected $246 million since the ACA went into effect. Last
year, for every dollar Mussallem's company brought in as revenue, two cents
went toward his pay.
The analysis still underestimates how much wealth health care CEOs have. It
did not include vested stock after CEOs retired, nor did it include the
value of stock CEOs still hold. For example, Walgreens CEO Stefano Pessina
owns more than 13% of Walgreens, which equaled about $12 billion as of June
2017.
n***j
发帖数: 1747
2
人为的。
美国医学相关的协会太黑了
g******t
发帖数: 11249
3
都是医保体系中的一员

【在 b****u 的大作中提到】
: 美国familiy中位数也就是5,6万。医生中位数要到20以上。5倍的差距。
: 提供发达国最差的服务。
: 美国医疗吸血能力仅次于墙街。
: 但是,墙街全世界吸血。 医疗可就只吸国内的血。
: 还有就是保险公司和医院医生狼狈为奸。
: The richest year was 2015, when 70 health care CEOs collectively made $2
: billion. That was an average of about $28.5 million per CEO and a median of
: about $17.3 million per CEO. The median household income in 2015 was $56,515
: , which the average health care CEO made in less than a day.2017年7月24日
: he sky-high pay of health care CEOs

b****u
发帖数: 337
4
但是美国人好像对这个没有任何异议。
比起被医疗搞走的钱,非移简直就不值一提。

【在 n***j 的大作中提到】
: 人为的。
: 美国医学相关的协会太黑了

o******t
发帖数: 1994
5
一提医生美国人肃然起敬的, 哪知道一堆庸医在那看病。 应该说是媒体洗脑洗的好,
医生的正面形象是刚刚的, 而且让你觉得医生就应该多挣钱。美国人被教育管理的很
乖, 一点不敢越雷池。

【在 b****u 的大作中提到】
: 但是美国人好像对这个没有任何异议。
: 比起被医疗搞走的钱,非移简直就不值一提。

q*********o
发帖数: 1299
6
非移的钱很多也是通过医疗搞走的。
比如非移去看病,啥也没有,医院也给看个够,然后说我赔了二十万,政府来补吧。

【在 b****u 的大作中提到】
: 但是美国人好像对这个没有任何异议。
: 比起被医疗搞走的钱,非移简直就不值一提。

1 (共1页)
进入Military版参与讨论
相关主题
too many asian CEOs ,破床的主要军师说美国民航CEO们在DC作证以后再也不打乘客了,哈哈
本男:硅谷的亚裔CEO太多了高通准备放弃收购NXP
的早期雇员,当年也是黑砖窑出来的伟创力的CEO是个三妹
聆听川胖中国学生都是间谍教诲的13位CEOScience:2013年度生物技术与制药行业最佳雇主
花了全世界最多的钱在医疗上给你们讲两三个毛时代的实际例子,让那个euv见识见识什么叫平
药厂CEO这么惨?lenovo要火了,杨元庆把3个米的奖金发给员工赢得老美一片赞誉
Gilead 公司大会,问CEO有关武汉病毒所的专利申请 (ZT)美国的贫富差距已经要赶上1929年大萧条的时的峰值了
我帝跟我兔接轨了,加大对金融肃贪的力度为什么印度裔比华裔在美国更成功?
相关话题的讨论汇总
话题: ceos话题: health话题: care话题: ceo话题: stock